Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116640146B reveals efficient Pd-catalyzed route for trifluoromethyl chromone quinoline intermediates offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Novel scalable route for tegoprazan key intermediate offering high purity ≥99% and simplified post-processing for reliable pharmaceutical supply chains.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API manufacturing without heavy metals.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Patent CN115286553B reveals nickel-catalyzed carbonylation for indole synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering high yields and broad substrate tolerance for API intermediates.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN111592507A reveals a metal-free route to polysubstituted furans using BF3 catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106938984B reveals a novel one-pot method for 5-substituted quinolines. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN115197124B reveals mild ammonium iodide catalysis for pyridine derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110590621B details a mild copper-catalyzed route for 1,2-bis(arylsulfonyl) ethylene derivatives, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN111410656B details a novel copper-catalyzed route to isoquinolinones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production capabilities.
Novel palladium-catalyzed route for 3-alkynylbenzofuran compounds ensures high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Patent CN110204487B reveals a green synthesis of quinoline derivatives using cheap copper catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel carbonylation method avoids toxic thiols using sulfonyl chlorides. High yield, scalable process ideal for reliable pharmaceutical intermediate manufacturing.
Novel Rhodium-catalyzed method for trifluoromethyl enaminones offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing and drug discovery.
Patent CN113683595B details sulfur-promoted cyclization. Eliminates heavy metals. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel metal-free synthesis method for trifluoroacetimide dihydrobenzofuran compounds offering high stereoselectivity and scalable production for pharmaceutical intermediates.
Patent CN120923511A details novel synthesis for vinyl indolo cyclic compounds with high enantioselectivity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.